688293 奥浦迈
等待开盘 11-15 09:30:00
资讯
新帖
简况
奥浦迈11月14日主力资金流入228万元 连续3日加仓
市场透视 · 11-14 15:20
奥浦迈11月14日主力资金流入228万元 连续3日加仓
奥浦迈大幅上涨 获融资净买入2378万元
智选洞察 · 11-13 13:12
奥浦迈大幅上涨 获融资净买入2378万元
奥浦迈:11月6日接受机构调研,包括知名机构明汯投资,聚鸣投资,正心谷资本的多家机构参与
证券之星 · 11-12 10:34
奥浦迈:11月6日接受机构调研,包括知名机构明汯投资,聚鸣投资,正心谷资本的多家机构参与
【机构调研记录】浙商基金调研奥浦迈
证券之星 · 11-12
【机构调研记录】浙商基金调研奥浦迈
【机构调研记录】华宝基金调研宏发股份、奥浦迈等3只个股(附名单)
证券之星 · 11-12
【机构调研记录】华宝基金调研宏发股份、奥浦迈等3只个股(附名单)
奥浦迈大幅上涨 获6家券商给予增持建议
智选洞察 · 11-11
奥浦迈大幅上涨 获6家券商给予增持建议
奥浦迈:Q3培养基高增 税率变动影响短期利润 海外市场增长亮眼
国盛证券 · 11-08
奥浦迈:Q3培养基高增 税率变动影响短期利润 海外市场增长亮眼
【机构调研记录】诺安基金调研国泰集团、奥浦迈等4只个股(附名单)
证券之星 · 11-06
【机构调研记录】诺安基金调研国泰集团、奥浦迈等4只个股(附名单)
【机构调研记录】汇丰晋信基金调研华勤技术、奥浦迈等4只个股(附名单)
证券之星 · 11-06
【机构调研记录】汇丰晋信基金调研华勤技术、奥浦迈等4只个股(附名单)
【机构调研记录】宝盈基金调研国泰集团、奥浦迈等3只个股(附名单)
证券之星 · 11-06
【机构调研记录】宝盈基金调研国泰集团、奥浦迈等3只个股(附名单)
【机构调研记录】安信基金调研奥浦迈、德赛西威
证券之星 · 11-06
【机构调研记录】安信基金调研奥浦迈、德赛西威
【机构调研记录】圆信永丰基金调研华勤技术、奥浦迈等3只个股(附名单)
证券之星 · 11-06
【机构调研记录】圆信永丰基金调研华勤技术、奥浦迈等3只个股(附名单)
【机构调研记录】国联基金调研国光股份、奥浦迈
证券之星 · 11-06
【机构调研记录】国联基金调研国光股份、奥浦迈
【机构调研记录】南华基金调研奥浦迈、广合科技
证券之星 · 11-06
【机构调研记录】南华基金调研奥浦迈、广合科技
国海证券给予奥浦迈买入评级,2024年三季报点评:培养基销售额显著增长,持续拓展客户数量
每日经济新闻 · 11-05
国海证券给予奥浦迈买入评级,2024年三季报点评:培养基销售额显著增长,持续拓展客户数量
奥浦迈:有知名机构高毅资产参与的多家机构于10月31日调研我司
证券之星 · 11-05
奥浦迈:有知名机构高毅资产参与的多家机构于10月31日调研我司
奥浦迈(688293.SH)股东上海磐信拟合计减持不超3%股份
智通财经 · 11-04
奥浦迈(688293.SH)股东上海磐信拟合计减持不超3%股份
奥浦迈:股东上海磐信拟减持不超3%股份
美港电讯 · 11-04
奥浦迈:股东上海磐信拟减持不超3%股份
奥浦迈(688293)11月1日主力资金净卖出103.43万元
证券之星 · 11-02
奥浦迈(688293)11月1日主力资金净卖出103.43万元
开源证券:给予奥浦迈买入评级
证券之星 · 11-01
开源证券:给予奥浦迈买入评级
暂无数据
公司概况
公司名称:
上海奥浦迈生物科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-09-02
主营业务:
上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司以细胞培养技术和工艺开发为基础,主营业务涉及细胞培养基系列产品和生物药委托开发生产服务两大应用领域。公司的主要产品有目培养基业务、CDMO业务、CHO培养基、293培养基。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。公司获得“高新技术企业”、上海市“专精特新”、上海市科技小巨人培育企业等称号。
发行价格:
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":44.35,"timestamp":1731634052000,"preClose":44.35,"halted":0,"volume":500,"delay":0,"floatShares":78633000,"shares":114999999,"eps":0.3319,"marketStatus":"等待开盘","marketStatusCode":7,"change":0,"latestTime":"11-15 09:30:00","open":44.35,"high":44.35,"low":44.35,"amount":22200,"amplitude":0,"askPrice":44.35,"askSize":1,"bidPrice":43.32,"bidSize":6,"shortable":0,"etf":0,"ttmEps":0.3319,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731634200000},"adr":0,"adjPreClose":44.35,"symbolType":"stock_kcb","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":48.79,"lowLimit":39.92,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":114772460,"pbRate":2.42,"roa":"--","roe":"1.26%","epsLYR":0.47,"committee":0.411111,"marketValue":5090000000,"floatMarketCap":3487000000,"peRate":133.624585,"changeRate":0,"turnoverRate":0,"status":2},"requestUrl":"/m/hq/s/688293/tweets","defaultTab":"tweets","newsList":[{"id":"2483846524","title":"奥浦迈11月14日主力资金流入228万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483846524","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483846524?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:20","pubTimestamp":1731568823,"startTime":"0","endTime":"0","summary":"11月14日, 奥浦迈股价跌3.59%,报收44.35元,成交金额4337万元,换手率1.25%,振幅7.39%,量比0.51。奥浦迈今日主力资金净流入228万元,连续3日净流入,上一交易日主力净流入290万元,今日环比减少21.38%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为45.45%,平均涨幅为2.62%。该股近5个交易日上涨11.01%,主力资金累计净流入1821万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入803万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153908abc01c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114153908abc01c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2483046837","title":"奥浦迈大幅上涨 获融资净买入2378万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483046837","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483046837?lang=zh_cn&edition=full","pubTime":"2024-11-13 13:12","pubTimestamp":1731474757,"startTime":"0","endTime":"0","summary":"11月13日,奥浦迈股价大幅上涨,截至13点12分,奥浦迈上涨5.01%,报46.15元/股,成交4994万元,换手率1.42%。资金动向截止发稿,奥浦迈获得主力净流入110万元,其中超大单流入203万元,大单流出93万元。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113131242a2327e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113131242a2327e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2482617715","title":"奥浦迈:11月6日接受机构调研,包括知名机构明汯投资,聚鸣投资,正心谷资本的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2482617715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482617715?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:34","pubTimestamp":1731378859,"startTime":"0","endTime":"0","summary":"奥浦迈主营业务:从事细胞培养产品与服务。该股最近90天内共有8家机构给出评级,买入评级5家,增持评级3家;过去90天内机构目标均价为36.0。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200012044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2482979599","title":"【机构调研记录】浙商基金调研奥浦迈","url":"https://stock-news.laohu8.com/highlight/detail?id=2482979599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482979599?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:04","pubTimestamp":1731369865,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为浙商智选领航三年持有混合A,最新单位净值为0.87,近一年增长20.5%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200006301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2482795629","title":"【机构调研记录】华宝基金调研宏发股份、奥浦迈等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482795629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482795629?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:02","pubTimestamp":1731369779,"startTime":"0","endTime":"0","summary":";公司产品已经成功应用到多个客户的多教智能眼镜及AR、VR硬件产品中华宝基金成立于2003年,截至目前,资产管理规模3234.45亿元,排名29/207;资产管理规模1636.77亿元,排名30/207;管理公募基金数233只,排名26/207;旗下公募基金经理41人,排名26/207。旗下最近一年表现最佳的公募基金产品为华宝中证金融科技主题ETF,最新单位净值为1.64,近一年增长46.55%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200006253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600885","LU2213484517.USD","LU1831875114.USD","688293","BK0169","BK0185","BK0028","BK0216","BK0196","LU0227179875.USD","LU1328615791.USD","BK0077","BK0224","BK0175","BK0078"],"gpt_icon":0},{"id":"2482224987","title":"奥浦迈大幅上涨 获6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2482224987","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482224987?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:48","pubTimestamp":1731293326,"startTime":"0","endTime":"0","summary":"资金动向截止发稿,奥浦迈获得主力净流出242万元,其中超大单流出148万元,大单流出93万元。主营业务及业绩奥浦迈公司主营业务为从事细胞培养产品与服务。最新财报显示,今年三季报,奥浦迈实现营业收入2.16亿元,同比增长25.73%,净利润为2,723.48万元,同比减少36.93%,基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111104853abb47007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111104853abb47007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2481127700","title":"奥浦迈:Q3培养基高增 税率变动影响短期利润 海外市场增长亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2481127700","media":"国盛证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481127700?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:00","pubTimestamp":1730995200,"startTime":"0","endTime":"0","summary":"奥浦迈发布2024 年三季度报告。观点:Q3 收入端高速增长,税率变更导致利润端阶段性承压,剔除税费影响后利润端正向改善。Q3 利润端阶段性承压,主要系公司被取消高新技术企业资格,自2024 年开始所得税税率由15%增至25%,Q3 集中补税导致利润端下滑。剔除因税率变动导致的税费影响后,2024Q3 归母净利润为808 万元,同比+52.48%,环比+77.14%,均实现正向改善。培养基延续高增态势,CDMO 业务逐季改善,海外市场增长势头强劲。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110819012095bdedb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110819012095bdedb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2481664966","title":"【机构调研记录】诺安基金调研国泰集团、奥浦迈等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481664966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481664966?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:04","pubTimestamp":1730851478,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为诺安积极回报混合A,最新单位净值为2.33,近一年增长52.88%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0229","603977","BK0216"],"gpt_icon":0},{"id":"2481664615","title":"【机构调研记录】汇丰晋信基金调研华勤技术、奥浦迈等4只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481664615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481664615?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:04","pubTimestamp":1730851463,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月5日披露的机构调研信息,汇丰晋信基金近期对4家上市公司进行了调研,相关名单如下:1)华勤技术 个股亮点:公司是专业从事智能硬件产品的研发设计、生产制造和运营服务的平台型公司,主要服务于国内外知名的智能硬件品牌厂商及互联网公司等,如三星、OPPO、小米、vivo、亚马逊、联想、宏碁、华硕、索尼等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603296","BK0214","688293","BK0216"],"gpt_icon":0},{"id":"2481514664","title":"【机构调研记录】宝盈基金调研国泰集团、奥浦迈等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481514664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481514664?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:03","pubTimestamp":1730851407,"startTime":"0","endTime":"0","summary":";全资子公司山西沁水新奥清洁能源有限公司主营液化天然气生产宝盈基金成立于2001年,截至目前,资产管理规模792.92亿元,排名69/207;资产管理规模514.46亿元,排名72/207;管理公募基金数120只,排名59/207;旗下公募基金经理18人,排名70/207。旗下最近一年表现最佳的公募基金产品为宝盈转型动力混合A,最新单位净值为1.18,近一年增长39.08%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688293","BK0216","603977"],"gpt_icon":0},{"id":"2481185664","title":"【机构调研记录】安信基金调研奥浦迈、德赛西威","url":"https://stock-news.laohu8.com/highlight/detail?id=2481185664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481185664?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:03","pubTimestamp":1730851406,"startTime":"0","endTime":"0","summary":";小米汽车SU7已经搭载了德赛西威的域控制器;公司联手英伟达,与理想汽车共同开发基于Orin的超强算力的自动驾驶系统集成,目前产品正在研发中安信基金成立于2011年,截至目前,资产管理规模1028.04亿元,排名59/207;资产管理规模904.84亿元,排名52/207;管理公募基金数176只,排名34/207;旗下公募基金经理34人,排名34/207。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","002920","BK0264","BK0216"],"gpt_icon":0},{"id":"2481952664","title":"【机构调研记录】圆信永丰基金调研华勤技术、奥浦迈等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481952664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481952664?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:03","pubTimestamp":1730851400,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月5日披露的机构调研信息,圆信永丰基金近期对3家上市公司进行了调研,相关名单如下:1)华勤技术 个股亮点:公司是专业从事智能硬件产品的研发设计、生产制造和运营服务的平台型公司,主要服务于国内外知名的智能硬件品牌厂商及互联网公司等,如三星、OPPO、小米、vivo、亚马逊、联想、宏碁、华硕、索尼等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216","BK0214","603296"],"gpt_icon":0},{"id":"2481166452","title":"【机构调研记录】国联基金调研国光股份、奥浦迈","url":"https://stock-news.laohu8.com/highlight/detail?id=2481166452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481166452?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:03","pubTimestamp":1730851398,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及11月5日披露的机构调研信息,国联基金近期对2家上市公司进行了调研,相关名单如下:1)国光股份 个股亮点:公司全资子公司重庆依尔双丰科技有限公司、全资子公司四川润尔科技有限公司草甘膦原药及含草甘膦成分制剂一共有八种产品。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293","002749","BK0229","BK0028"],"gpt_icon":0},{"id":"2481645046","title":"【机构调研记录】南华基金调研奥浦迈、广合科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2481645046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481645046?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:03","pubTimestamp":1730851383,"startTime":"0","endTime":"0","summary":"南华基金成立于2016年,截至目前,资产管理规模155.63亿元,排名125/207;资产管理规模155.63亿元,排名110/207;管理公募基金数32只,排名122/207;旗下公募基金经理8人,排名124/207。旗下最近一年表现最佳的公募基金产品为南华瑞盈混合发起A,最新单位净值为1.3,近一年增长13.02%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0214","BK0216","001389"],"gpt_icon":0},{"id":"2481150264","title":"国海证券给予奥浦迈买入评级,2024年三季报点评:培养基销售额显著增长,持续拓展客户数量","url":"https://stock-news.laohu8.com/highlight/detail?id=2481150264","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481150264?lang=zh_cn&edition=full","pubTime":"2024-11-05 21:39","pubTimestamp":1730813983,"startTime":"0","endTime":"0","summary":"国海证券11月04日发布研报称,给予奥浦迈(688293.SH,最新价:40.3元)买入评级。评级理由主要包括:1)培养基销售额显著增长,海外业务增长势头强劲;2)中试项目总数大幅增加,持续拓展国内外客户数量。风险提示:1、投融资不景气,行业增长降速;2、竞争格局恶化,影响行业价格体系;3、地缘政治扰动,海外增长乏力;4、培养基配方流失,影响公司核心竞争力;5、核心技术人员离职。AI点评:奥浦迈近一个月获得3份券商研报关注,买入1家。文章来源:每日经济新闻原标题:国海证券给予奥浦迈买入评级,2024年三季报点评:培养基销售额显著增长,持续拓展客户数量","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105214925a218abc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105214925a218abc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000750","688293"],"gpt_icon":0},{"id":"2481657094","title":"奥浦迈:有知名机构高毅资产参与的多家机构于10月31日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481657094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481657094?lang=zh_cn&edition=full","pubTime":"2024-11-05 20:10","pubTimestamp":1730808645,"startTime":"0","endTime":"0","summary":"目前来看,在现行市场环境下,CDMO业务终端价格承压较大是目前大家面临的普遍的情况,公司必须通过内部整合不断提高生产效率促使CDMO业务能够获得更多的利润。该股最近90天内共有6家机构给出评级,买入评级3家,增持评级3家;过去90天内机构目标均价为36.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500034446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2480372727","title":"奥浦迈(688293.SH)股东上海磐信拟合计减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2480372727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480372727?lang=zh_cn&edition=full","pubTime":"2024-11-04 18:00","pubTimestamp":1730714401,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥浦迈(688293.SH)发布公告,奥浦迈于2024年11月3日收到公司持股5%以上股东北京磐茂投资管理有限公司-磐信(上海)投资中心(有限合伙)(简称“上海磐信”)发来的《关于股东减持计划告知函》,因股东自身资金需求,上海磐信计划自2024年11月26日起至2025年2月22日期间,通过大宗交易和集中竞价交易的方式合计减持公司股份不超过344.32万股,合计减持比例占公司目前总股本的比例不超过3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2480914372","title":"奥浦迈:股东上海磐信拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2480914372","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480914372?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:54","pubTimestamp":1730714064,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688293","BK0216"],"gpt_icon":0},{"id":"2480898887","title":"奥浦迈(688293)11月1日主力资金净卖出103.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480898887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480898887?lang=zh_cn&edition=full","pubTime":"2024-11-02 08:19","pubTimestamp":1730506742,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月1日收盘,奥浦迈报收于39.09元,上涨1.51%,换手率2.04%,成交量1.61万手,成交额6280.52万元。近5日资金流向一览见下表:奥浦迈融资融券信息显示,融资方面,当日融资买入597.8万元,融资偿还708.73万元,融资净偿还110.94万元。奥浦迈主营业务:从事细胞培养产品与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110200005572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"gpt_icon":0},{"id":"2480880954","title":"开源证券:给予奥浦迈买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480880954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480880954?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:50","pubTimestamp":1730472638,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,聂媛媛近期对奥浦迈进行研究并发布了研究报告《公司信息更新报告:培养基业务维持高增长,税率变动致利润阶段性承压》,本报告对奥浦迈给出买入评级,当前股价为39.09元。2024年前三季度,公司培养基等产品业务实现收入1.80亿元,同比增长59.15%;CDMO业务实现收入0.36亿元,同比下滑39.05%。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级2家,增持评级3家;过去90天内机构目标均价为36.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100049742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","161027"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","stockEarnings":[{"period":"1week","weight":0.1101},{"period":"1month","weight":0.3731},{"period":"3month","weight":0.5566},{"period":"6month","weight":0.2231},{"period":"1year","weight":-0.2303},{"period":"ytd","weight":-0.1846}],"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","perCapita":"24696股","boardName":"研究和试验发展","registeredCapital":"11477万元","compareEarnings":[{"period":"1week","weight":-0.0262},{"period":"1month","weight":0.0558},{"period":"3month","weight":0.1738},{"period":"6month","weight":0.0716},{"period":"1year","weight":0.0999},{"period":"ytd","weight":0.1361}],"survey":" 上海奥浦迈生物科技股份有限公司是一家专门从事细胞培养产品与服务的高新技术企业。公司以细胞培养技术和工艺开发为基础,主营业务涉及细胞培养基系列产品和生物药委托开发生产服务两大应用领域。公司的主要产品有目培养基业务、CDMO业务、CHO培养基、293培养基。公司及其子公司已获得5项发明专利,62项实用新型专利和2项外观专利。公司获得“高新技术企业”、上海市“专精特新”、上海市科技小巨人培育企业等称号。","serverTime":1731634067882,"listedPrice":80.2,"stockholders":"3184人(较上一季度减少2.78%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}